The increasing prevalence of neurodegenerative conditions such as Parkinson's disease
(PD) and related mobility issues places a serious burden on healthcare systems. The COVID …

Parkinson's disease (PD) is affecting about 1.2 million patients in Europe with a prevalence
that is expected to have an exponential increment, in the next decades. This epidemiological …

In recent times, there has been a significant growth in networks known as the wireless body
area networks (WBANs). A WBAN connects distributed nodes throughout the human body …

As the motor symptoms of Parkinson's disease (PD) are complex and influenced by many
factors, it is challenging to quantify gait abnormalities adequately using a single type of …

Wearable technology used in Parkinson's disease (PD) research has become an increasing
focus of interest in this field. Our group assessed the feasibility, clinical correlation, reliability …

Phenotype is the set of observable traits of an organism or condition. While advances in
genetics, imaging, and molecular biology have improved our understanding of the …

Background Peripheral artery disease (PAD) is a cardiovascular disease that can be
improved by risk factor modification. Mobile health (mHealth) intervention is an effective …

Parkinson's disease (PD) is the second most common neurodegenerative disorder, with
increasing numbers of affected patients. Many patients lack adequate care due to insufficient …

Using deep learning has demonstrated significant potential in making informed decisions
based on clinical evidence. In this study, we deal with optimizing medication and …

With the advent of the Internet of Things (IoT) concept and its integration with the smart city
sensing, smart connected health systems have appeared as integral components of the …